切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2018, Vol. 11 ›› Issue (06) : 415 -419. doi: 10.3877/cma.j.issn.1674-6880.2018.06.013

所属专题: 文献

综述

肠道微生态与脓毒症
王慧芳1, 王方岩2, 常平1, 刘占国1,()   
  1. 1. 510282 广州,南方医科大学珠江医院重症医学科
    2. 325035 浙江温州,温州医科大学病理生理教研室
  • 收稿日期:2018-09-23 出版日期:2018-12-01
  • 通信作者: 刘占国
  • 基金资助:
    国家自然科学基金项目(81101451)
  • Received:2018-09-23 Published:2018-12-01
引用本文:

王慧芳, 王方岩, 常平, 刘占国. 肠道微生态与脓毒症[J]. 中华危重症医学杂志(电子版), 2018, 11(06): 415-419.

1
Floch MH. Intestinal microecology in health and well-ness[J]. J Clin Gastroenterol, 2011 (45 Suppl): S108-S110.
2
Schwalm ND 3rd, Groisman EA. Navigating the gut buffet: control of polysaccharide utilization in bacteroides spp[J]. Trends Microbiol, 2017, 25 (12): 1005-1015.
3
Di Cerbo A, Palmieri B, Aponte M, et al. Mechanisms and therapeutic effectiveness of lactobacilli[J]. J Clin Pathol, 2016, 69 (3): 187-203.
4
Qin H, Zhang Z, Hang X, et al. L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells[J]. BMC Microbiol, 2009 (9): 63.
5
Liu Y, Fatheree NY, Mangalat N, et al. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-kappaB signaling in the intestine[J]. Am J Physiol Gastrointest Liver Physiol, 2012, 302 (6): G608-G617.
6
Shen Z, Zhu C, Quan Y, et al. Update on intestinal microbiota in Crohn's disease 2017: mechanisms, clinical application, adverse reactions, and outlook[J]. J Gastroenterol Hepatol, 2017, 32 (11): 1804-1812.
7
Kaakoush NO, Day AS, Huinao KD, et al. Microbial dysbiosis in pediatric patients with Crohn's disease[J]. J Clin Microbiol, 2012, 50 (10): 3258-3266.
8
任洁,罗彦英. 肠道微生物与肠道疾病[J]. 中国中西医结合外科杂志,2015,21(6): 632-635.
9
李姝敏,张勤,吴月,等. 老年人大便性状与肠道菌群的相关性分析[J/CD]. 中华危重症医学杂志(电子版),2018,11(4): 217-222.
10
Mittal R, Coopersmith CM. Redefining the gut as the motor of critical illness[J]. Trends Mol Med, 2014, 20 (4): 214-223.
11
Fay KT, Ford ML, Coopersmith CM. The intestinal microenvironment in sepsis[J]. Biochim Biophys Acta, 2017, 1863 (10 Pt B): 2574-2583.
12
Haak BW, Wiersinga WJ. The role of the gut micro-biota in sepsis[J]. Lancet Gastroenterol Hepatol, 2017, 2 (2): 135-143.
13
Jacobs MC, Haak BW, Hugenholtz F, et al. Gut mic-robiota and host defense in critical illness[J]. Curr Opin Crit Care, 2017, 23 (4): 257-263.
14
李云,金国强. 头孢曲松钠对脓毒症大鼠肠道微生态环境的影响[J]. 江西医药,2016,51(12): 1347-1349.
15
边金泂,周祖模,张苏江. 头孢曲松和亚胺培南对脓毒症大鼠肠道菌群及细菌耐药性的影响[J]. 中国生化药物杂志,2014,34(3): 34-36.
16
Shimizu K, Ogura H, Hamasaki T, et al. Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome[J]. Dig Dis Sci, 2011, 56 (4): 1171-1177.
17
Romanowski K, Zaborin A, Fernandez H, et al. Prevention of siderophore-mediated gut-derived sepsis due to P. aeruginosa can be achieved without iron provision by maintaining local phosphate abundance: role of pH[J]. BMC Microbiol, 2011 (11): 212.
18
Condotta SA, Cabrera-Perez J, Badovinac VP, et al. T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression[J]. Crit Rev Immunol, 2013, 33 (1): 23-40.
19
Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis[J]. JAMA, 2012, 307 (18): 1959-1969.
20
Zaborin A, Defazio JR, Kade M, et al. Phosphate-con-taining polyethylene glycol polymers prevent lethal sepsis by multidrug-resistant pathogens[J]. Antimicrob Agents Chemother, 2014, 58 (2): 966-977.
21
Romanowski K, Zaborin A, Valuckaite V, et al. Can-dida albicans isolates from the gut of critically ill patients respond to phosphate limitation by expressing filaments and a lethal phenotype[J]. PLoS One, 2012, 7 (1): e30119.
22
Zaborina O, Zaborin A, Romanowski K, et al. Host stress and virulence expression in intestinal pathogens: development of therapeutic strategies using mice and C. elegans[J]. Curr Pharm Des, 2011, 17 (13): 1254-1260.
23
Ferrer M, Mendez-Garcia C, Rojo D, et al. Antibiotic use and microbiome function[J]. Biochem Pharmacol, 2017 (134): 114-126.
24
侯杰,郭应军,邓冲. 危重患者抗生素相关性肠炎与抗生素的合理使用[J]. 广东医学,2010,31(8): 1002-1003.
25
Shimizu K, Ogura H, Goto M, et al. Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report[J]. Dig Dis Sci, 2009, 54 (5): 1071-1078.
26
李素彦,徐鑫,杨运强,等. 不同时期应用益生菌对脓毒症患者肠道菌群及短链脂肪酸的影响[J]. 河北医药,2015,37(23): 3567-3571.
27
Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial[J]. Am J Respir Crit Care Med, 2010, 182 (8): 1058-1064.
28
Llewellyn A, Foey A. Probiotic modulation of innate cell pathogen sensing and signaling events[J]. Nutrients, 2017, 9 (10): 1156.
29
李晗宇,陈路芳,李金优,等. 益生菌制剂对脓毒症小鼠生存情况的影响及机制研究[J/CD]. 中华危重症医学杂志(电子版),2017,10(5): 289-295.
30
Shimizu K, Yamada T, Ogura H, et al. Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial[J]. Crit Care, 2018, 22 (1): 239.
31
Wan X, Bi J, Gao X, et al. Partial enteral nutrition preserves elements of gut barrier function, including innate immunity, intestinal alkaline phosphatase (IAP) level, and intestinal microbiota in mice[J]. Nutrients, 2015, 7 (8): 6294-6312.
32
Shimizu K, Ogura H, Asahara T, et al. Gastrointestinal dysmotility is associated with altered gut flora and septic mortality in patients with severe systemic inflammatory response syndrome: a preliminary study[J]. Neurogastroenterol Motil, 2011, 23 (4): 330-335, e157.
33
Klingensmith NJ, Coopersmith CM. Fecal microbiota transplantation for multiple organ dysfunction syndrome[J]. Crit Care, 2016, 20 (1): 398.
34
Acharya C, Bajaj JS. The microbiome in cirrhosis and its complications[J]. Clin Gastroenterol Hepatol, 2018, In press.
35
Cussotto S, Sandhu KV, Dinan TG, et al. The neur-oendocrinology of the microbiota-gut-brain axis: a behavioural perspective[J]. Front Neuroendocrinol, 2018 (51): 80-101.
36
Li Q, Wang C, Tang C, et al. Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case report[J]. Crit Care, 2015 (19): 37.
37
Wei Y, Yang J, Wang J, et al. Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis[J]. Crit Care, 2016, 20 (1): 332.
No related articles found!
阅读次数
全文


摘要